In congestive heart failure after myocardial infarction, hydrochlorothiazide improves heart remodeling by reducing the levels of proinflammatory cytokines and inhibiting the TGFβ signaling pathway [64]. This evidence concerns the gene TGFB1 and congestive heart failure.